Min Mu

Mrs. Min Mu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017
Verified
Journal Article
Open access
MMMin Mu
Min Mu
LXLi-Fa Xu
Li-Fa Xu
DHDong Hu
Dong Hu
JWJing Wu
Jing Wu
MBMing-Jie Bai
Ming-Jie Bai
Background: Dietary patterns analysis may provide insights into the influence of overall diet on overweight/obesity. In the past two decades, the relation between dietary patterns and overweight/obesity has been a research focus and a number of results were reported in the research field. Methods: An electronic literature search was conducted in PubMed and Web of Science, to identify human studies published by Mar 2015 and written in English. The following keywords or phrases were involved: dietary patterns, dietary pattern, factor analysis, principal component analysis, diet, obesity, adiposity, overweight and BMI. All the studies were retrieved and prudent/healthy (n = 17) and western/unhealthy (n = 18) dietary patterns were identified. Results: When compared with the lowest categories of a prudent/healthy dietary pattern, a reduced overweight/obesity risk was shown in the highest (OR = 0.64; 95% CI: 0.52, 0.78; P<0.0001). While there was an increased overweight/obesity risk in the highest when compared with the lowest categories of a western/unhealthy dietary pattern (OR = 1.65; 95% CI: 1.45, 1.87; P<0.0001). Conclusion: A prudent/healthy dietary pattern and limit intake of western/unhealthy dietary pattern should be followed, which helps to keep a healthy body mass.

1 December 2021 in Toxicology Letters
Verified
Journal Article
Closed access
BLBing Li
Bing Li
MMMin Mu
Min Mu
QSQixian Sun
Qixian Sun
HCHangbing Cao
Hangbing Cao
QLQiang Liu
Qiang Liu
JWJianhua Wang
Jianhua Wang

12 February 2022 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YZYuanjie Zou
Yuanjie Zou
MMMin Mu
Min Mu
SZSiyuan Zhang
Siyuan Zhang
CLChuansuo Li
Chuansuo Li
KTKai Tian
Kai Tian
XTXing-Rong Tao
Xing-Rong Tao

30 November 2023 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
YLYuting Lu
Yuting Lu
MMMin Mu
Min Mu
XRXiaotian RenChen
Xiaotian RenChen
WWWenyang Wang
Wenyang Wang
YZYingrui Zhu
Yingrui Zhu
XTXinrong Tao
Xinrong Tao
Inhaling silica causes the occupational illness silicosis, which mostly results in the gradual fibrosis of lung tissue. Previous research has demonstrated that hypoxia-inducible factor-1α (HIF-1α) and glycolysis-related genes are up-regulated in silicosis. The role of 2-deoxy-D-glucose (2-DG) as an inhibitor of glycolysis in silicosis mouse models and its molecular mechanisms remain unclear. Therefore, we used 2-DG to observe its effect on pulmonary inflammation and fibrosis in a silicosis mouse model. Furthermore, in vitro cell experiments were conducted to explore the specific mechanisms of HIF-1α. Our study found that 2-DG down-regulated HIF-1α levels in alveolar macrophages induced by silica exposure and reduced the interleukin-1β (IL-1β) level in pulmonary inflammation. Additionally, 2-DG reduced silica-induced pulmonary fibrosis. From these findings, we hypothesize that 2-DG reduced glucose transporter 1 (GLUT1) expression by inhibiting glycolysis, which inhibits the expression of HIF-1α and ultimately reduces transcription of the inflammatory cytokine, IL-1β, thus alleviating lung damage. Therefore, we elucidated the important regulatory role of HIF-1α in an experimental silicosis model and the potential defense mechanisms of 2-DG. These results provide a possible effective strategy for 2-DG in the treatment of silicosis.

27 October 2020 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
PDF file
ZJZhou Jiawei
Zhou Jiawei
MMMin Mu
Min Mu
XYXing Yingru
Xing Yingru
ZXZhang Xin
Zhang Xin
LDLi Danting
Li Danting
DHDong Hu
Dong Hu
Background: The development of human tumors is associated with the abnormal expression of various functional genes, and a massive tumor-based database needs to be deeply mined. Based on a multigene prediction model, access to urgent prognosis of patients has become possible. Materials and Methods: We selected three RNA expression profiles (GSE32863, GSE10072, and GSE43458) from the lung adenocarcinoma (LUAD) database of the Gene Expression Omnibus (GEO) and analyzed the differentially expressed genes (DEGs) between tumor and normal tissue using GEO2R program. After that, we analyzed the transcriptome data of 479 LUAD samples (54 normal tissue samples and 425 cancer tissue samples) and their clinical follow-up data from the (TCGA) database. Kaplan–Meier (KM) curve and receiver operating characteristic (ROC) were used to assess the prediction model. Multivariate Cox analysis was used to identify independent predictors. TCGA pancreatic adenocarcinoma datasets were used to establish a nomogram model. Results: We found 98 significantly prognosis-related genes using KM and COX analysis, among which six genes were found to be the DEGs in GEO. Using multivariate analysis, it was found that a single gene could not be used as an independent predictor of prognosis. However, the risk score calculated by weighting these six genes could serve as an independent prognosis predictor. COX analysis performed with multiple covariates such as age, gender, tumor stage, and TNM typing showed that risk score could still be utilized as an independent risk factor for patient survival rate (p = 0.013) and had an applicable reliability (area under the curve, AUC = 0.665). By combining risk score and various clinical features, the nomogram model was constructed, which had been proven to have high consistency for the prediction of 3- and 5-year survival rate (concordance = 0.751) and high accuracy as tested by ROC (AUC = 0.71;AUC = 0.708). Conclusion: We proposed a method to predict the prognosis of LUAD by weighting multiple genes and constructed a nomogram model suitable for the prognostic evaluation of LUAD, which could provide a new tool for the identification of therapeutic targets and the efficacy evaluation of LUAD.

6 June 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
MDMiaomiao Du
Miaomiao Du
SHSuxia Hu
Suxia Hu
WCWeiya Cao
Weiya Cao
BLBing Li
Bing Li
HJHaibo Jin
Haibo Jin
MMMin Mu
Min Mu